Psychotropic medication use and risk of adverse cardiovascular events in women with suspected coronary artery disease: Outcomes from the Women's Ischemia Syndrome Evaluation (WISE) study

Heart

Volumn 95, Issue 23, 2009, Pages 1901-1906

  Krantz, David S ^a   Whittaker, K S ^a   Francis, J L ^a   Rutledge, T ^b   Johnson, B D ^c   Barrow, G ^c   McClure, C ^c   Sheps, D S ^d   York, K ^d   Cornell, C ^e   Bittner, V ^f   Vaccarino, V ^g   Eteiba, W ^c   Parashar, S ^g   Vido, D A ^h   Bairey Merz, C N ⁱ  

^a Uniformed Services University of the Health Sciences   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g EMORY UNIVERSITY   (United States)

^h ALLEGHENY GENERAL HOSPITAL   (United States)

ⁱ CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

ADULT; ANGIOCARDIOGRAPHY; ANXIETY DISORDER; ARTICLE; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; STROKE; SURVIVAL RATE; UNSTABLE ANGINA PECTORIS;

ADOLESCENT; ADULT; AGED; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; CAUSE OF DEATH; CORONARY ANGIOGRAPHY; DEPRESSIVE DISORDER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RISK FACTORS; YOUNG ADULT;

EID: 72049100088     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2009.176040     Document Type: Article

References (32)

1. Blumenthal JA, Lett HS, Babyak MA, et al. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 2003;362:604-609 (Pubitemid 37013300)
2. Frasure-Smith N, Lesperance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry 2008;65:62-71.
3. Whang W, Kubzansky LD, Kawachi I, et al. Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study. J Am Coll Cardiol 2009;53:950-958
4. Lesperance F, Frasure-Smith N, Koszycki D, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007;297:367-379 (Pubitemid 46155798)
5. Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002;288:701-709 (Pubitemid 34848222)
6. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003;289:3106-3116 (Pubitemid 37432886)
7. Taylor CB, Youngblood ME, Catellier D, et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 2005;62:792-798 (Pubitemid 41002762)
8. Roose SP, Glassman AH, Attia E, et al. Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am J Psychiatry 1998;155:660-665 (Pubitemid 28225407)
9. Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 2001;104:1894-1898 (Pubitemid 32983230)
10. Sala M, Coppa F, Cappucciati C, et al. Antidepressants: their effects on cardiac channels, QT prolongation and torsade de pointes. Curr Opin Investig Drugs 2006;7:256-263
11. Bigger JT Jr, Weld FM. Drugs and sudden cardiac death. Ann N Y Acad Sci 1982;382:229-237
12. Ray WA, Meredith S, Thapa PB, et al. Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther 2004;75:234-241 (Pubitemid 38314873)
13. Cannon RO 3rd, Quyyumi AA, Mincemoyer R, et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 1994;330:1411-1417
14. Narayan SM, Stein MB. Do depression or antidepressants increase cardiovascular mortality? The absence of proof might be more important than the proof of absence. J Am Coll Cardiol 2009;53:959-961
15. Sherwood A, Blumenthal JA, Trivedi R, et al. Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med 2007;167:367-373 (Pubitemid 46333937)
16. Xiong GL, Jiang W, Clare R, et al. Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting. Am J Cardiol 2006;98:42-47 (Pubitemid 43902679)
17. Merlo J, Hedblad B, Ogren M, et al. Increased risk of ischaemic heart disease mortality in elderly men using anxiolytics-hypnotics and analgesics. Results of the 10-year follow-up of the prospective population study "Men born in 1914", Malmo, Sweden. Eur J Clin Pharmacol 1996;49:261-265
18. Lapane KL, Zierler S, Lasater TM, et al. Is the use of psychotropic drugs associated with increased risk of ischemic heart disease? Epidemiology 1995;6:376-381
19. Paulose-Ram R, Safran MA, Jonas BS, et al. Trends in psychotropic medication use among U.S. adults. Pharmacoepidemiol Drug Saf 2007;16:560-570 (Pubitemid 46824278)
20. Merz CN, Kelsey SF, Pepine CJ, et al. The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J Am Coll Cardiol 1999;33:1453-1461
21. Rutledge T, Reis SE, Olson MB, et al. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-sponsored WISE study. Arch Gen Psychiatry 2006;63:874-880 (Pubitemid 44188480)
22. Watkins L, Blumenthal J, Davidson J, et al. Antidepressant use in coronary heart disease patients: impact on survival. Psychosom Med 2006;68:A95.
23. Paulose-Ram R, Jonas BS, Orwig D, et al. Prescription psychotropic medication use among the U.S. adult population: results from the third National Health and Nutrition Examination Survey, 1988-1994. J Clin Epidemiol 2004;57:309-317
24. Watkins LL, Davidson JR, McCants CB, et al. Antidepressant use in coronary heart disease patients: impact on survival. Psychosom Med 2006;68:A95.
25. Agelink MW, Majewski TB, Andrich J, et al. Short-term effects of intravenous benzodiazepines on autonomic neurocardiac regulation in humans: a comparison between midazolam, diazepam, and lorazepam. Crit Care Med 2002;30:997-1006. (Pubitemid 34508020)
26. Kawachi I, Sparrow D, Vokonas PS, et al. Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation 1994;90:2225-2229
27. Sherbourne CD, Wells KB. Course of depression in patients with comorbid anxiety disorders. J Affect Disord 1997;43:245-250 (Pubitemid 27242471)
28. Watkins LL, Blumenthal JA, Davidson JR, et al. Phobic anxiety, depression, and risk of ventricular arrhythmias in patients with coronary heart disease. Psychosom Med 2006;68:651-656 (Pubitemid 44454631)
29. Beitman BD, Mukerji V, Lamberti JW, et al. Panic disorder in patients with chest pain and angiographically normal coronary arteries. Am J Cardiol 1989;63:1399-1403 (Pubitemid 19135048)
30. Johnson BD, Shaw LJ, Pepine CJ, et al. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study. Eur Heart J 2006;27:1408-1415
31. Shaw LJ, Olson MB, Kip K, et al. The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 2006;47(3 Suppl):S36-43. (Pubitemid 43170829)
32. Shaw LJ, Merz CN, Pepine CJ, et al. The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health - National Heart, Lung, and Blood Institute - sponsored Women's Ischemia Syndrome Evaluation. Circulation 2006;114:894-904.